VOYA Investment Management
OLMA icon

VOYA Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History

VOYA Investment Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
121,927
+433
+0.4% +$5.8K ﹤0.01% 1351
2026
Q1 		$1.81M Buy
121,494
+95,503
+367% +$2.13M ﹤0.01% 1231
2025
Q4 		$650K Buy
25,991
+14,909
+135% +$265K ﹤0.01% 1638
2025
Q3 		$108K Sell
11,082
-5,498
-33% -$33K ﹤0.01% 2288
2025
Q2 		$70.6K Buy
16,580
+4,801
+41% +$21.4K ﹤0.01% 2550
2025
Q1 		$44.3K Sell
11,779
-744
-6% -$3.74K ﹤0.01% 2564
2024
Q4 		$73K Sell
12,523
-39,695
-76% -$396K ﹤0.01% 2640
2024
Q3 		$623K Buy
52,218
+20,746
+66% +$265K ﹤0.01% 1884
2024
Q2 		$341K Sell
31,472
-98,115
-76% -$1.06M ﹤0.01% 2199
2024
Q1 		$1.47M Buy
129,587
+118,486
+1,067% +$1.53M ﹤0.01% 1466
2023
Q4 		$156K Buy
11,101
+258
+2% +$3.47K ﹤0.01% 2649
2023
Q3 		$134K Hold
10,843
– – ﹤0.01% 2659
2023
Q2 		$97.9K Buy
+10,843
New +$65.5K ﹤0.01% 2791
2021
Q4 		– Sell
-9,650
Closed -$266K – 2810
2021
Q3 		$266K Buy
+9,650
New +$260K ﹤0.01% 2404

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

VOYA Investment Management's OLMA Position: Q2 2026 in Review

VOYA Investment Management increased its Olema Pharmaceuticals (OLMA) stake by 0.36% in Q2 2026, buying an estimated $5.8K and bringing the position to 121,927 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

VOYA Investment Management first reported a position in OLMA in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.81M in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • VOYA Investment Management held 121,927 shares of Olema Pharmaceuticals worth $1.53M as of Q2 2026.
  • VOYA Investment Management bought 433 Olema Pharmaceuticals shares in Q2 2026, an estimated $5.8K.
  • Olema Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1351 holding.
  • VOYA Investment Management first reported a position in Olema Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
  • VOYA Investment Management's Olema Pharmaceuticals position peaked at $1.81M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.